However, the metabolism of CSPGs undergoes marked alterations in the articular cartilage of JIA patients, as evidenced by the significant reductions in concentration of both sulfated glycosaminoglycans and aggrecan degradation products in the synovial fluid of these individuals, compared not only with osteoarthritis patients but also healthy subjects [24]. The gene discussed is ACAN; the disease is juvenile idiopathic arthritis.